DRTS
Alpha Tau Medical Ltd. NASDAQ Listed Mar 8, 2021$9.95
-0.80%
vs $10.03
Mkt Cap $898.7M
52w Low $2.87
80.9% of range
52w High $11.62
50d MA $9.10
200d MA $6.36
P/E (TTM)
—
EV/EBITDA
—
P/B
10.4x
Debt/Equity
0.2x
ROE
-55.3%
P/FCF
-24.7x
RSI (14)
53.30
ATR (14)
$0.77
Beta
1.05
50d MA
$9.10
200d MA
$6.36
Avg Volume
1.1M
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
5 Kiryat Hamada Street · Jerusalem, L3 9777605 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | AMC | -0.13 | -0.14 | -7.7% | 6.71 | -0.7% | +1.9% | +2.9% | -1.0% | +2.9% | +1.1% | — |
| Nov 20, 2025 | AMC | -0.12 | -0.14 | -16.7% | 3.47 | -1.2% | +10.1% | -4.5% | +6.8% | -4.1% | +6.1% | — |
| Aug 11, 2025 | AMC | -0.12 | -0.13 | -8.3% | 3.56 | -1.7% | -8.7% | +5.2% | -6.4% | +2.5% | -0.6% | — |
| May 19, 2025 | AMC | -0.14 | -0.12 | +14.3% | 3.10 | +4.8% | +5.2% | -4.6% | -3.5% | +0.0% | +2.3% | — |
| Mar 12, 2025 | AMC | -0.13 | -0.13 | +0.0% | 2.66 | +1.1% | -1.5% | +1.1% | +0.4% | -1.5% | -0.8% | — |
| Aug 14, 2024 | AMC | -0.13 | -0.11 | +15.4% | 2.11 | +0.5% | +6.6% | -3.1% | -0.9% | +0.9% | +0.0% | — |
| May 20, 2024 | AMC | -0.13 | -0.11 | +15.4% | 2.71 | +7.4% | +0.0% | +0.0% | -2.2% | -4.5% | -2.4% | — |
| Mar 7, 2024 | AMC | -0.13 | -0.11 | +15.4% | 3.03 | -1.0% | -0.7% | -0.3% | -3.3% | +0.7% | -2.7% | — |
| Nov 16, 2023 | AMC | -0.12 | -0.07 | +41.7% | 2.93 | +0.0% | +4.1% | -4.9% | -3.8% | +7.2% | +1.7% | — |
| Aug 28, 2023 | AMC | -0.13 | -0.12 | +7.7% | 3.25 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% | — |
| May 23, 2023 | AMC | -0.09 | -0.12 | -33.3% | 3.71 | -2.4% | +3.5% | -1.6% | +2.4% | +1.3% | +1.3% | — |
| Mar 9, 2023 | AMC | -0.12 | -0.04 | +66.7% | 3.30 | +0.9% | -1.5% | -7.4% | +4.5% | -2.4% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 | Barclays | Initiates | Overweight | $15 | $10.29 | $10.51 | +2.1% | -1.6% | +6.9% | -10.8% | -7.6% | +18.5% |
| Mar 11 | Citigroup | Maintains | Buy → Buy | — | $6.84 | $6.88 | +0.6% | +2.9% | -1.0% | +2.9% | +1.1% | +3.0% |
| Mar 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.71 | $6.66 | -0.7% | +1.9% | +2.9% | -1.0% | +2.9% | +1.1% |
| Mar 4 | Piper Sandler | Downgrade | Overweight → Neutral | — | $7.07 | $6.78 | -4.1% | -0.7% | +1.4% | -10.0% | +4.7% | +1.9% |
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.31 | $7.48 | +2.3% | +1.2% | +13.8% | -5.8% | -2.1% | -1.7% |
| Dec 10 | Citigroup | Maintains | Buy → Buy | — | $4.23 | $4.55 | +7.6% | +19.6% | -2.0% | +1.8% | +1.2% | +0.6% |
| Nov 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.82 | $3.85 | +0.8% | -4.5% | +6.8% | -4.1% | +6.1% | -4.8% |
| Oct 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.20 | $4.27 | +1.7% | -3.8% | +4.2% | +0.5% | -1.7% | +1.0% |
| Sep 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.48 | $3.55 | +2.0% | +1.4% | -1.1% | +3.2% | +2.5% | +5.7% |
| Apr 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.64 | $2.67 | +1.1% | +2.7% | -5.5% | +2.3% | -0.8% | +0.0% |
| Mar 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.65 | $2.66 | +0.4% | +0.4% | -1.5% | -0.8% | +0.0% | +0.4% |
| Nov 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.30 | $2.31 | +0.4% | +0.9% | +9.1% | +13.0% | -2.1% | +0.0% |
| Oct 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.21 | $2.24 | +1.4% | +1.8% | -1.3% | -0.9% | +0.5% | +5.4% |
| Oct 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.25 | $2.20 | -2.2% | -2.2% | -1.4% | +0.5% | +4.6% | +0.9% |
| Aug 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.16 | +0.0% | +0.9% | +0.0% | +2.3% | -1.3% | +2.7% |
| Aug 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.11 | $2.12 | +0.5% | +6.6% | -3.1% | -0.9% | +0.9% | +0.0% |
| Jun 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.35 | +8.8% | +2.3% | -7.2% | +23.4% | +0.8% | -14.5% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.71 | $2.72 | +0.4% | +0.0% | -2.2% | -4.5% | -2.4% | +0.0% |
| May 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.65 | $2.68 | +1.1% | +0.8% | +6.0% | -4.2% | +0.0% | +0.0% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.00 | $3.00 | +0.0% | -3.3% | +0.7% | -2.7% | +0.4% | +1.1% |
| Mar 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.03 | $3.00 | -1.0% | -0.7% | -0.3% | -3.3% | +0.7% | -2.7% |
| Nov 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.05 | $2.98 | -2.3% | -4.9% | -3.8% | +7.2% | +1.7% | +0.7% |
| Nov 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.93 | $2.93 | +0.0% | +4.1% | -4.9% | -3.8% | +7.2% | +1.7% |
| Sep 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.35 | $3.39 | +1.2% | +3.3% | -7.5% | +2.5% | -9.1% | +2.3% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.25 | $3.27 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% |
| Aug 29 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $3.25 | $3.27 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% |
| Aug 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.60 | $4.10 | +13.9% | +2.8% | -4.3% | +2.0% | -1.4% | -4.5% |
| May 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.71 | $3.62 | -2.4% | +3.5% | -1.6% | +2.4% | +1.3% | +1.3% |
| May 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.35 | $3.46 | +3.3% | +3.0% | +4.1% | +10.9% | -6.8% | +3.5% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.87 | $4.10 | +5.9% | -3.1% | -9.6% | -1.2% | +3.0% | +4.1% |
| Apr 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.85 | $3.00 | +5.3% | +8.1% | +4.9% | -8.4% | -1.4% | +4.8% |
| Nov 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.75 | $3.84 | +2.4% | +3.2% | +20.4% | -9.9% | -4.8% | -0.2% |
| Apr 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $10.58 | $10.38 | -1.9% | -10.5% | +7.7% | -2.6% | -10.3% | +14.1% |
| Apr 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.20 | $11.62 | +3.8% | +0.4% | -11.4% | +6.8% | -0.6% | -10.5% |
| Apr 4 | Citigroup | Maintains | Buy → Buy | — | $10.54 | $11.86 | +12.5% | +13.5% | +5.9% | -3.4% | -8.5% | +0.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Levy Raphi | Chief Financial Officer | Sell | 15,000 | $10.76 | $161K | 147,680 | -9.14% | +4.76% |
| Jun 3, 2026 | Levy Raphi | Chief Financial Officer | Sell | 17,500 | $10.90 | $191K | 162,680 | -9.14% | +4.76% |
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Hightower Advisors, Llc | 686,554 | $3M | — | Dec 2025 |
| 2 | Apella Capital, Llc | 382,284 | $3M | — | Mar 2026 |
| 3 | Ark Investment Management Llc | 292,134 | $2M | New | Mar 2026 |
| 4 | Ubs Group Ag | 286,688 | $2M | Added | Mar 2026 |
| 5 | Northcoast Asset Management Llc | 147,138 | $1M | Reduced | Mar 2026 |
| 6 | Daytona Street Capital Llc | 146,106 | $1M | Reduced | Mar 2026 |
| 7 | Gem Investment Advisors, Llc | 113,736 | $804K | Reduced | Mar 2026 |
| 8 | Wells Fargo & Company/mn | 49,300 | $349K | New | Mar 2026 |
| 9 | Private Advisor Group, Llc | 47,583 | $336K | — | Mar 2026 |
| 10 | Millennium Management | 46,445 | $328K | Reduced | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 41,392 | $293K | Added | Mar 2026 |
| 12 | Renaissance Technologies Llc | 40,457 | $286K | New | Mar 2026 |
| 13 | Citadel Advisors Llc | 35,395 | $250K | New | Mar 2026 |
| 14 | Northern Trust Corp | 33,333 | $236K | Reduced | Mar 2026 |
| 15 | Susquehanna International Group, Llp | 32,738 | $231K | New | Mar 2026 |
| 16 | Focus Partners Wealth | 32,265 | $228K | — | Mar 2026 |
| 17 | Morgan Stanley | 38,226 | $189K | Reduced | Dec 2025 |
| 18 | Woodstock Corp | 20,609 | $146K | New | Mar 2026 |
| 19 | Neuberger Berman Group Llc | 15,000 | $106K | New | Mar 2026 |
| 20 | Quent Capital, Llc | 20,000 | $99K | New | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | ARK Israel Innovative Technology ETF | 292,134 | $2M | Jan 2026 |
Valuation
Market Cap
$898.7M
Enterprise Value
$737.7M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.53x
P/B
10.40x
P/S
—
P/FCF
-24.67x
EV/EBITDA
—
Shares Out
80.6M
Financials (TTM)
Revenue
$0
Net Income
-$56.9M
EBITDA
-$44.9M
Free Cash Flow
-$32.8M
Op Cash Flow
-$26.7M
EPS Basic
$-0.53
EPS Diluted
$-0.67
EPS Forward
$-0.51
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$106.6M
Total Liab.
$29.5M
Total Equity
$77.1M
Cash
$76.9M
LT Debt
$6.4M
Book Value/Sh
$0.96
Debt/Equity
0.18x
Current Ratio
7.45
Quick Ratio
7.45
Returns & Growth
ROE
-55.3%
ROA
-40.4%
ROIC
-43.5%
Rev Growth YoY
+0.0%
EPS Growth YoY
-17.8%
Price Returns
2W
+4.0%
1M
+29.9%
3M
+39.6%
6M
+172.8%
12M
+262.2%
Technicals
52W High
$11.62
52W Low
$2.87
50d MA
$9.10
200d MA
$6.36
RSI (14)
53.30
ATR (14)
$0.77
Beta
1.05
Avg Volume
1.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$12.00
High
$12.00
Low
$12.00
Median
$12.00
Data updated apr 25, 2026 5:47am
· Source: financialmodelingprep.com